Advertisement

The Scientist

» cancer, microbiology and genetics & genomics

Most Recent

image: Designing Transition-State Inhibitors

Designing Transition-State Inhibitors

By | May 1, 2012

A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. 

0 Comments

image: The Sugar Lnc

The Sugar Lnc

By | May 1, 2012

Genes that react to cellular sugar content are regulated by a long non-coding RNA via an unexpected mechanism

2 Comments

image: Tumor Turnabout

Tumor Turnabout

By | May 1, 2012

A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.

4 Comments

image: Bubble Vision

Bubble Vision

By | May 1, 2012

Turning a liability into an asset, cryo-electron microscopists exploit an artifact to probe protein structure.

0 Comments

image: Freezing Time

Freezing Time

By | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

image: SPRead Your Antibody Capabilities

SPRead Your Antibody Capabilities

By | May 1, 2012

Using surface plasmon resonance to improve antibody detection and characterization: four case studies

0 Comments

image: Telomeres in Disease

Telomeres in Disease

By | May 1, 2012

Telomeres have been linked to numerous diseases over the years, but how exactly short telomeres cause diseases and how medicine can prevent telomere erosion are still up for debate.

16 Comments

image: Illegal Genes

Illegal Genes

By | April 30, 2012

California mulls a state law that would criminalize the unauthorized sharing, storing, or analyzing of genetic data.

0 Comments

image: The Best of Experimental Biology

The Best of Experimental Biology

By | April 25, 2012

From breast milk stem cells to bone repair, this year’s EB conference held a number of exciting advances that could one day be translated into therapies.

4 Comments

image: Genomics Boom Continues

Genomics Boom Continues

By | April 16, 2012

A new report estimates that the genomics research tools market will be worth nearly $9 billion by 2016.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement